← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
CGTBiologicstaleUniversity College, LondonPhase 1

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

CD19+ Malignancies: Relapse Post-allogeneic Transplant · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 77.3%임상시험 2상태 ACTIVE
CGTBiologicstaleShenzhen Geno-Immune Medical In…Preclinical

Intrathecal and intravenous LV gene therapy (Intrathecal and intravenous LV gene therapy)

X-linked Adrenoleukodystrophy · Metachromatic Leukodystrophy (MLD)

#MetachromaticLeukodystrophyMLD#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
AntibodystaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Hepatocellular Carcinoma (HCC); Immunotherapy · Hepatecellular Carcinoma

#HepatecellularCarcinoma#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
CGTBiologicstaleJuno Therapeutics, a Subsidiary…Phase 2

JCARH125 (JCARH125)

Non Hodgkin Lymphoma; Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 42.9%임상시험 2상태 ACTIVE
ADCBiologicstaleJanssen Research & Development,…Phase 1

JNJ-95298177 (JNJ-95298177)

Prostatic Neoplasms · Prostatic Neoplasms

#ProstaticNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
CGTBiologicstaleChristian HinrichsPhase 1

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

Gastric Cancer; Breast Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleNanjing Legend Biotech Co.Phase 1

LCAR-AIO T cells (LCAR-AIO T cells)

Multiple Sclerosis (MS); Neuromyelitis Optica Spectrum Disease (NMOSD) · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
ADCBiologicstaleEli Lilly and CompanyPhase 1

LY4170156 (LY4170156)

Ovarian Neoplasms; Endometrial Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleMerckPhase 1

pembrolizumab (Keytruda, Letetresgene autoleucel with pembrolizumab)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#항체#면역항체+2
효능 ORR 33.3%임상시험 2상태 DISCONTINUED
CGTBiologicstaleSeigo NishidaPhase 1

Liver NK cell inoculation (Liver NK cell inoculation)

Liver Cirrhosis; Hepatocellular Carcinoma · Liver Cirrhosis

#LiverCirrhosis#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
ADCBiologicstaleEMD Serono Research & Developme…Phase 2

M6223 (M6223)

Metastatic Solid Tumors · Locally Advanced or Metastatic Urothelia

#LocallyAdvancedorMetastaticUroth#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleMenarini GroupPhase 1

MEN1309 (MEN1309)

Metastatic Solid Tumors; Relapsed/Refractory Non-Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 DISCONTINUED
CGTBiologicstaleAnhui Kecheng intelligent healt…Phase 2

METR-NK cell（metabolic remodeling nature killer cells） (METR-NK cell（metabolic remodeling nature killer cells）)

Ovarian Cancer · Ovary Cancer

#OvaryCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
ADCBiologicLepu Biopharma Co., Ltd.Phase 2

MRG006A (MRG006A)

Hepatocellular Carcinoma · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleMerck KGaAPhase 1

Methotrexate/Vinblastine/Doxorubicin/Cisplatin/Avelumab (Methotrexate/Vinblastine/Doxorubicin/Cisplatin/Avelumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#Antibody#Phase1#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleTakedaPhase 2

Mezagitamab (Mezagitamab)

Relapsed and/or Refractory Multiple Myeloma (RRMM) · FRα

#FR#Antibody#Phase2#항체#면역항체+4
효능 ORR 25%임상시험 2상태 ACTIVE
CGTBiologicstaleGuangdong Xiangxue Precision Me…Phase 2

NY-ESO-1（TCR Affinity Enhancing Specific T cell Therapy） (NY-ESO-1（TCR Affinity Enhancing Specific T cell Therapy）)

Soft Tissue Sarcoma · Bone Sarcoma

#BoneSarcoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
AntibodystaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleRoswell Park Cancer InstitutePhase 1

Nimotuzumab (Nimotuzumab)

EGFR Gene Mutation; Recurrent Non-Small Cell Lung Carcinoma · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#항체#면역항체+4
임상시험 2상태 ACTIVE

70 / 209 페이지

← 이전다음 →